Floatz logo

299 assets in Lung Cancer

Therapeutic assets addressing Lung Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
[225Ac]-FPI-1966
Lung Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
3h-10000
Lung Cancer
3H Pharmaceuticals Co., Ltd.P1/2CC (41)
a2b395
Lung Cancer
A2 Biotherapeutics Inc.P1/2CC (41)
a2b543
Lung Cancer
A2 Biotherapeutics Inc.P1/2CC (41)
a2b694
Lung Cancer
A2 Biotherapeutics Inc.P1/2CC (41)
Amivantamab-Vmjw
Lung Cancer
University of Colorado, DenverP1/2CC (41)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)-
Lung Cancer
VM Oncology, LLCP1/2CC (41)
bt02
Lung Cancer
Biotroy TherapeuticsP1CC (41)
Carbon Nanoparticle-Loaded Iron
Lung Cancer
Sichuan Enray Pharmaceutical Sciences CompanyP1/2CC (41)
Difluoromethylornithine
Lung Cancer
H. Lee Moffitt Cancer Center and Research InstituteP1/2CC (41)
Elimusertib
Lung Cancer
National Cancer Institute (NCI)P1CC (41)
Fermented Wheat Germ Extract
Lung Cancer
University of California, DavisP1CC (41)
Gilteritinib
Lung Cancer
University of Michigan Rogel Cancer CenterP1CC (41)
Icasp9M28Z T Cell Infusions
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (41)
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer
Lung Cancer
University of SaskatchewanP1/2CC (41)
Inupadenant
Lung Cancer
iTeos Belgium SAP1/2CC (41)
Mrx-2843
Lung Cancer
Emory UniversityP1CC (41)
Obx-115
Lung Cancer
Obsidian Therapeutics, Inc.P1/2CC (41)
Pbf-1129
Lung Cancer
Dwight OwenP1CC (41)
Pumitamig
Lung Cancer
Bristol-Myers SquibbP1/2CC (41)
Recombinant Fully Human Igg1 Kappa Anti-Tigit Monoclonal Antibody Eos-448
Lung Cancer
iTeos Belgium SAP1/2CC (41)
Rezatapopt
Lung Cancer
PMV Pharmaceuticals, IncP1/2CC (41)
Sonidegib
Lung Cancer
Mayo ClinicP1CC (41)
Sugemalimab
Lung Cancer
Sichuan UniversityP1/2CC (41)
t3011
Lung Cancer
ImmVira Pharma Co. LtdP1/2CC (41)
Tegavivint
Lung Cancer
Ohio State University Comprehensive Cancer CenterP1CC (41)
tng260
Lung Cancer
Tango Therapeutics, Inc.P1/2CC (41)
tng456
Lung Cancer
Tango Therapeutics, Inc.P1/2CC (41)
tng462
Lung Cancer
Tango Therapeutics, Inc.P1/2CC (41)
Triptolide Analog
Lung Cancer
City of Hope Medical CenterP1CC (41)
Tucatinib
Lung Cancer
Jonathan RiessP1CC (41)
Valemetostat
Lung Cancer
National Cancer Institute (NCI)P1/2CC (41)
Vismodegib
Lung Cancer
Dwight OwenP1CC (41)
Vofatamab
Lung Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
wsd0922-fu
Lung Cancer
Mayo ClinicP1CC (41)
Autologous Dendritic Cell-Adenovirus Ccl21 Vaccine
Lung Cancer
Jonsson Comprehensive Cancer CenterP1CC (40)
bi 765049
Lung Cancer
Boehringer IngelheimP1CC (40)
Carotuximab
Lung Cancer
Karen Reckamp, MD, MSP1CC (40)
Cnsi-Fe
Lung Cancer
Sichuan Enray Pharmaceutical Sciences CompanyP1CC (40)
Ezabenlimab
Lung Cancer
Boehringer IngelheimP1CC (40)
NC 410
Lung Cancer
NextCure, Inc.P1/2CC (40)
Palbociclib
Lung Cancer
Lebanese UniversityP1CC (40)
Egfr/B7H3 Car-T
Lung Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityEarly P1C (39)
PRT1419
Lung Cancer
Prelude TherapeuticsP1C (39)
bmd006
Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (38)
[177lu]lu-evs459
Lung Cancer
Novartis PharmaceuticalsP1C (37)
18f-αvβ6-bp
Lung Cancer
University of California, DavisP1C (37)
[68ga]ga-evs459
Lung Cancer
Novartis PharmaceuticalsP1C (37)
Azenosertib
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
bg-60366
Lung Cancer
BeOne MedicinesP1C (37)
Showing 201 to 250 of 299 assets
PreviousPage 5 of 6Next